Stay updated on PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T21:25:16.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T19:50:02.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now displays a new revision label: Revision: v3.4.2. This is a minor meta-update and does not alter study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-02-12T02:22:00.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.4.1 added and v3.4.0 removed; this appears to be an internal version update with no changes to the page content or study information.
    Difference
    0.1%
    Check dated 2026-02-04T12:32:11.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    A glossary toggle was added and QC/version metadata was updated (Last Update Submitted that Met QC Criteria and Revision: v3.4.0); FEAR Act data labeling was adjusted.
    Difference
    0.2%
    Check dated 2026-01-28T11:11:20.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Revision v3.3.4 was added and Revision v3.3.3 was removed; this is a routine page update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:42:34.000Z thumbnail image

Stay in the know with updates to PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page.